Загрузка...
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
BACKGROUND: Nephrotic syndrome is a disorder characterized by proteinuria, hypoalbuminemia and dyslipidemia. Low-dose alternate-day steroid regimen is the standard of care. In case of relapse or significant adverse events, steroid-sparing agents may be used. This analysis was aimed at assessing the...
Сохранить в:
| Опубликовано в: : | Ital J Pediatr |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943005/ https://ncbi.nlm.nih.gov/pubmed/27405390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-016-0271-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|